SOLESENCE, INC. — Director's Dealing 2017

Feb 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2017-02-21

Reporting Person: CESARIO FRANK (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-21	Common Stock (right to purchase)	$0.68	A	36000	Acquired	2027-02-21	Common Stock (36000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	83783	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (right to buy)	$1.07	2019-06-24	Common Stock (20000)	20000	Direct
Common Stock (right to buy)	$1.70	2020-05-03	Common Stock (20000)	20000	Direct
Common Stock (right to buy)	$1.26	2021-05-02	Common Stock (31000)	31000	Direct
Common Stock (right to buy)	$0.30	2022-08-07	Common Stock (13667)	13667	Direct
Common Stock (right to buy)	$0.415	2023-02-14	Common Stock (13000)	13000	Direct
Common Stock (right to buy)	$0.52	2024-02-13	Common Stock (40000)	40000	Direct
Common Stock (right to buy)	$0.44	2025-02-18	Common Stock (36000)	36000	Direct
Common Stock	$0.42	2026-02-23	Common Stock (31500)	31500	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.